Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (21 total)
-
Créateur: NETEC SPRN Medical Countermeasures Working Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-02-19
Description: Emerging and re-emerging infectious diseases pose growing global public health threats. However, research on and development of medical countermeasures (MCMs) for such pathogens is limited by the sporadic and unpredictable nature of outbreaks, lack… -
Créateur: Kraft, C. S.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2016-11-15
Description: Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)... -
Créateur: WHO
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2019-04-12
Description: The World Health Organization (WHO) is supporting the acceleration of new Ebola interventions in Africa, in particular the development of additional candidate vaccines. This site provides data reviewed by the WHO on the suitability of candidate… -
Créateur: Fallah MP, Skrip LA.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Créateur: CDC
Sujet: Personnel Management
Type d'élément: Guide
Date de la dernière mise à jour: 2019-04-16
Description: Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States. -
Créateur: Dean, Natalie E., Pierre-Stéphane Gsell, Ron Brookmeyer, Forrest W. Crawford, Christl A. Donnelly, Susan S. Ellenberg, Thomas R. Fleming, M. Elizabeth Halloran, Peter Horby, Thomas Jaki, Philip R. Krause, Ira M. Longini, Sabue Mulangu, Jean-Jacques…
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-02
Description: Conducting trials of novel interventions during infectious disease emergencies, such as the ongoing Covid-19 pandemic, is increasingly recognized as important for determining the efficacy of potential vaccines and therapies. -
Créateur: University of Minnesota, Center for Infectious Disease Research and Policy
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2017-01-17
Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced. -
Créateur: ACTT- Study Group
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2022-05-23
Description: Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to… -
Créateur: Furtado, Remo H. M., Otavio Berwanger, Henrique A. Fonseca, Thiago D. Corrêa, Leonardo R. Ferraz, Maura G. Lapa, Fernando G. Zampieri, Viviane C. Veiga, Luciano C. P. Azevedo, Regis G. Rosa, Renato D. Lopes, Alvaro Avezum, Airton L. O. Manoel, Felipe…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-09-08
Description: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes of patients admitted to the… -
Créateur: National Institute of Allergy and Infectious Diseases (NIAID)
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2020-05-07
Description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in…